Ifg Advisory, LLC Bristol Myers Squibb CO Transaction History

Ifg Advisory, LLC

$1.54 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$48.48 - $57.85 $581 - $694	12 Added 0.27%	4,418 $226,000
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $255,063 - $285,200	4,406 New	4,406 $255,000
Q1 2023 Apr 26, 2023	BUY	$65.71 - $74.53 $86,540 - $98,156	1,317 Added 43.51%	4,344 $301,000
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $435,738 - $515,975	-6,363 Reduced 67.76%	3,027 $217,000
Q3 2022 Oct 28, 2022	BUY	$0.13 - $76.84 $786 - $465,035	6,052 Added 181.31%	9,390 $667,000
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $1,815 - $1,999	-25 Reduced 0.74%	3,338 $257,000
Q1 2022 May 04, 2022	SELL	$61.48 - $73.72 $4,611 - $5,529	-75 Reduced 2.18%	3,363 $245,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $209,371 - $244,078	-3,904 Reduced 53.17%	3,438 $214,000
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $4,378 - $5,128	74 Added 1.02%	7,342 $434,000
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $18,387 - $20,023	297 Added 4.26%	7,268 $485,000
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $5,518 - $6,206	-93 Reduced 1.32%	6,971 $440,000
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $4,850 - $5,496	84 Added 1.2%	7,064 $438,000
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $21,823 - $24,183	380 Added 5.76%	6,980 $420,000
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $5,865 - $6,857	107 Added 1.65%	6,600 $388,000
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $301,275 - $437,822	6,493 New	6,493 $361,000
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $703,352 - $833,925	-16,445 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $534,592 - $591,142	11,981 Added 268.39%	16,445 $190,000
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $25,312 - $30,181	561 Added 14.37%	4,464 $212,000
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $58,316 - $75,623	-1,196 Reduced 23.46%	3,903 $202,000
Q3 2018 Nov 05, 2018	BUY	$55.19 - $62.25 $2,649 - $2,988	48 Added 0.95%	5,099 $316,000
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $17,533 - $21,854	-347 Reduced 6.43%	5,051 $279,000
Q1 2018 Apr 26, 2018	BUY	$59.92 - $68.98 $11,864 - $13,658	198 Added 3.81%	5,398 $0
Q4 2017 Feb 01, 2018	SELL	$59.94 - $65.35 $839,699 - $915,488	-14,009 Reduced 72.93%	5,200 $318,000
Q4 2017 Jan 29, 2018	BUY	$59.94 - $65.35 $1.15 Million - $1.26 Million	19,209	19,209 $321,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.2 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.4 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.51 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.62 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.62 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.

Account